Supplementary Table S2 from Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib–treated Patients with <i>BRAF</i><sup>V600</sup>-mutated Metastatic Melanoma
收藏NIAID Data Ecosystem2026-05-26 收录
数据链接：
官方服务：
资源简介：
Supplementary Table S2 from Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib–treated Patients with BRAFV600-mutated Metastatic Melanoma
创建时间：
2019-06-01
